Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Allografting

Challenges in the use of allogeneic hematopoietic SCT for ectodermal dysplasia with immune deficiency

Bone Marrow Transplantation volume 43, pages 217–221 (2009)Cite this article

Abstract

Genetic mutations of proteins regulating nuclear factor of κ-light polypeptide gene enhancer in B lymphocyte (NF-κB) activation result in heritable diseases of development and immunity. Hypomorphic, X-linked mutations in the IKBKG gene (NF-κB essential modulator (NEMO) protein), and hypermorphic, autosomal dominant mutations in the IKBA gene (inhibitor of NF-κB (IκB)-α protein), are associated with a phenotype of immune deficiency and often ectodermal dysplasia (ED-ID). ED-ID predisposes patients to recurrent and life-threatening infections and is typically fatal within the first few years of life. Allogeneic hematopoietic SCT (HSCT) may correct the immune deficiency associated with NEMO or IκBα mutations, but there is very little published data. We gathered clinical data on three ED-ID patients that had undergone HSCT. Conditioning regimens were variable, as were the stem cell sources. All three patients experienced engraftment difficulties as well as post transplant complications. These cases suggest that patients with immune deficiencies caused by NEMO or IκBα mutations may have intrinsic barriers to successful engraftment, which require further investigation.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Singh H, Sen R, Baltimore D, Sharp PA . A nuclear factor that binds to a conserved sequence motif in transcriptional control elements of immunoglobulin genes. Nature 1986; 319: 154–158.

    Article  CAS  PubMed  Google Scholar 

  2. Ghosh S, Karin M . Missing pieces in the NF-kappaB puzzle. Cell 2002; 109 (Suppl): S81–S96.

    Article  CAS  PubMed  Google Scholar 

  3. Yamamoto Y, Gaynor RB . IkappaB kinases: key regulators of the NF-kappaB pathway. Trends Biochem Sci 2004; 29: 72–79.

    Article  CAS  PubMed  Google Scholar 

  4. Orange JS, Levy O, Geha RS . Human disease resulting from gene mutations that interfere with appropriate nuclear factor-kappaB activation. Immunol Rev 2005; 203: 21–37.

    Article  CAS  PubMed  Google Scholar 

  5. Zonana J, Elder ME, Schneider LC, Orlow SJ, Moss C, Golabi M et al. A novel X-linked disorder of immune deficiency and hypohidrotic ectodermal dysplasia is allelic to incontinentia pigmenti and due to mutations in IKK-gamma (NEMO). Am J Hum Genet 2000; 67: 1555–1562.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Abinun M . Ectodermal dysplasia and immunodeficiency. Arch Dis Child 1995; 73: 185.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Doffinger R, Smahi A, Bessia C, Geissmann F, Feinberg J, Durandy A et al. X-linked anhidrotic ectodermal dysplasia with immunodeficiency is caused by impaired NF-kappaB signaling. Nat Genet 2001; 27: 277–285.

    Article  CAS  PubMed  Google Scholar 

  8. Frix III CD, Bronson DM . Acute miliary tuberculosis in a child with anhidrotic ectodermal dysplasia. Pediatr Dermatol 1986; 3: 464–467.

    Article  PubMed  Google Scholar 

  9. Orange JS, Jain A, Ballas ZK, Schneider LC, Geha RS, Bonilla FA . The presentation and natural history of immunodeficiency caused by nuclear factor kappaB essential modulator mutation. J Allergy Clin Immunol 2004; 113: 725–733.

    Article  CAS  PubMed  Google Scholar 

  10. Schweizer P, Kalhoff H, Horneff G, Wahn V, Diekmann L . Polysaccharide specific humoral immunodeficiency in ectodermal dysplasia. Case report of a boy with two affected brothers. Klin Padiatr 1999; 211: 459–461.

    Article  CAS  PubMed  Google Scholar 

  11. Sitton JE, Reimund EL . Extramedullary hematopoiesis of the cranial dura and anhidrotic ectodermal dysplasia. Neuropediatrics 1992; 23: 108–110.

    Article  CAS  PubMed  Google Scholar 

  12. Orange JS, Brodeur SR, Jain A, Bonilla FA, Schneider LC, Kretschmer R et al. Deficient natural killer cell cytotoxicity in patients with IKK-gamma/NEMO mutations. J Clin Invest 2002; 109: 1501–1509.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Gatti RA, Meuwissen HJ, Allen HD, Hong R, Good RA . Immunological reconstitution of sex-linked lymphopenic immunological deficiency. Lancet 1968; 2: 1366–1369.

    Article  CAS  PubMed  Google Scholar 

  14. Reisner Y, Kapoor N, Kirkpatrick D, Pollack MS, Cunningham-Rundles S, Dupont B et al. Transplantation for severe combined immunodeficiency with HLA-A,B,D,DR incompatible parental marrow cells fractionated by soybean agglutinin and sheep red blood cells. Blood 1983; 61: 341–348.

    CAS  PubMed  Google Scholar 

  15. Antoine C, Muller S, Cant A, Cavazzana-Calvo M, Veys P, Vossen J et al. Long-term survival and transplantation of haemopoietic stem cells for immunodeficiencies: report of the European experience 1968–99. Lancet 2003; 361: 553–560.

    Article  PubMed  Google Scholar 

  16. Buckley RH, Schiff SE, Schiff RI, Markert L, Williams LW, Roberts JL et al. Hematopoietic stem-cell transplantation for the treatment of severe combined immunodeficiency. N Engl J Med 1999; 340: 508–516.

    Article  CAS  PubMed  Google Scholar 

  17. Buckley RH . A historical review of bone marrow transplantation for immunodeficiencies. J Allergy Clin Immunol 2004; 113: 793–800.

    Article  PubMed  Google Scholar 

  18. Dupuis-Girod S, Cancrini C, Le Deist F, Palma P, Bodemer C, Puel A et al. Successful allogeneic hemopoietic stem cell transplantation in a child who had anhidrotic ectodermal dysplasia with immunodeficiency. Pediatrics 2006; 118: e205–e211.

    Article  PubMed  Google Scholar 

  19. Dupuis-Girod S, Corradini N, Hadj-Rabia S, Fournet JC, Faivre L, Le Deist F et al. Osteopetrosis, lymphedema, anhidrotic ectodermal dysplasia, and immunodeficiency in a boy and incontinentia pigmenti in his mother. Pediatrics 2002; 109: e97.

    Article  PubMed  Google Scholar 

  20. Tono C, Takahashi Y, Terui K, Sasaki S, Kamio T, Tandai S et al. Correction of immunodeficiency associated with NEMO mutation by umbilical cord blood transplantation using a reduced-intensity conditioning regimen. Bone Marrow Transplant 2007; 39: 801–804.

    Article  CAS  PubMed  Google Scholar 

  21. Mancini AJ, Lawley LP, Uzel G . X-linked ectodermal dysplasia with immunodeficiency caused by NEMO mutation: early recognition and diagnosis. Arch Dermatol 2008; 144: 342–346.

    Article  PubMed  Google Scholar 

  22. Orstavik KH, Kristiansen M, Knudsen GP, Storhaug K, Vege A, Eiklid K et al. Novel splicing mutation in the NEMO (IKK-gamma) gene with severe immunodeficiency and heterogeneity of X-chromosome inactivation. Am J Med Genet A 2006; 140: 31–39.

    Article  PubMed  Google Scholar 

  23. Courtois G, Smahi A, Reichenbach J, Doffinger R, Cancrini C, Bonnet M et al. A hypermorphic IkappaBalpha mutation is associated with autosomal dominant anhidrotic ectodermal dysplasia and T cell immunodeficiency. J Clin Invest 2003; 112: 1108–1115.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  24. Nenci A, Becker C, Wullaert A, Gareus R, van Loo G, Danese S et al. Epithelial NEMO links innate immunity to chronic intestinal inflammation. Nature 2007; 446: 557–561.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pediatrics, Division of Oncology, Children's Hospital of Philadelphia, Philadelphia, PA, USA

    J D Fish & N Bunin

  2. Department of Pediatrics, Division of Hematology–Oncology–Stem Cell Transplant, Children's Memorial Hospital, Chicago, IL, USA

    R E Duerst

  3. Department of Pediatrics, National Jewish Medical and Research Center, Denver, CO, USA

    E W Gelfand

  4. Department of Pediatrics, Division of Allergy and Immunology, The Children's Hospital of Philadelphia, Philadelphia, PA, USA

    J S Orange

Authors
  1. J D Fish
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. R E Duerst
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. E W Gelfand
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. J S Orange
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. N Bunin
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to N Bunin.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Fish, J., Duerst, R., Gelfand, E. et al. Challenges in the use of allogeneic hematopoietic SCT for ectodermal dysplasia with immune deficiency. Bone Marrow Transplant 43, 217–221 (2009). https://doi.org/10.1038/bmt.2008.308

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/bmt.2008.308

Keywords

This article is cited by

Search

Advanced search

Quick links